Centrus Energy Corp. (LEU) Q3 2026 earnings review
Centrus nearly doubles fuel backlog, but quarterly operations lose money
Centrus Energy, the nuclear fuel supplier, locked in billions in future orders and shipped its first new centrifuge while its current fuel deliveries lost money. Third-quarter revenue dropped 26% on lighter uranium delivery volume, and a $9 million loss excluding one-offs replaced last year's profit. Chief executive Amir Vexler held the full-year sales outlook steady, so by our math the plan points to 14% growth in the fourth quarter.
| Revenue | $55.5M -26% from a year ago |
|---|---|
| Net loss, excluding one-offs | -$9.4M $5.2M profit a year ago |
| Enriched uranium segment backlog | $6.2B up from $3.7B last quarter |
| Full-year revenue outlook | Unchanged middle of the range: 6% growth |
⚖️ Verdict: 🟢 Bullish
The story got better because customers signed binding contracts for $5.1 billion of future fuel, more than double last quarter's $2.4 billion, and Oak Ridge finished its first centrifuge two months early. The bad news: rising supply costs and a shrinking federal contract pushed both operating divisions into gross losses, while a $494 million stock and warrant sale diluted shareholders.
The question now is whether the $5.4 billion contingent order book converts into profitable cash flow fast enough to justify today's construction spending and share dilution. Optimists point to early factory milestones and binding contracts, while skeptics note that new capacity produces nothing before 2029 and upfront customer advances have not risen. Fourth-quarter fuel margins and the long-term financial targets at December's investor day will tell.
🐂 Bull Case
Enriched Uranium Backlog Nearly Doubled on Signed Contracts
Centrus enriches uranium for nuclear power plants and tracks future demand through its order backlog. Critics point out that most of this backlog is contingent on building new plant capacity in Piketon, Ohio, with no guaranteed profit. This quarter, the fuel segment's backlog rose by $2.5 billion to $6.2 billion, and almost all of the increase came in binding customer contracts.
- Total company backlog: $7.0 billion, up from $4.5 billion last quarter
- Enriched uranium segment backlog: $6.2 billion, up 107% from a year ago by our math
- Contingent sales commitments: $5.4 billion, up from $3.0 billion last quarter
- Commitments under definitive agreements: $5.1 billion, up from $2.4 billion last quarter
That jump matters because customers are converting preliminary letters into binding agreements before the Ohio plant is built. By our math, unsigned contingent commitments shrank from $600 million last quarter to $300 million today, so the commercial order book is firming up even though deliveries remain tied to construction milestones.
What to watch: customer prepayments and deferred revenue in the full-year report. A rise in cash advances would show that these newly signed contracts are helping pay for the Ohio build-out.
First Centrifuge Shipped Two Months Ahead of Schedule
To turn its $5.4 billion contingent backlog into revenue, Centrus must manufacture thousands of uranium-enriching machines called centrifuges at its plant in Oak Ridge, Tennessee, and install them in Ohio. President and chief executive Amir Vexler highlighted "shipping the first new centrifuge to support our commercial-scale expansion" as the quarter's key milestone.
The nuclear fuel supplier also finished signing contracts with all critical supply-chain partners and completed its first certified construction package. Both tasks were "reached two months ahead of our ambitious schedule and puts us far ahead of the competition", Vexler said. In addition, the company began enriching high-assay low-enriched uranium (HALEU), a specialized fuel for next-generation reactors, for commercial buyers using its existing 16-centrifuge line.
Finishing the supply-chain contracts and the first centrifuge early reduces the risk of an immediate bottleneck as factory spending scales up. What to watch: the production schedule and delivery targets at the upcoming investor day. Clear dates for full cascade installation will show whether the 2029 startup target holds.
🐻 Bear Case
Higher Enrichment Costs and Warrant Gains Hid Operating Losses
Centrus reported $31.6 million in net income, up from $3.9 million a year ago, while Vexler praised execution across all parts of the business. That headline profit came entirely from a $46.4 million accounting gain on the changing value of warrant liabilities, not from selling nuclear fuel.
- Cost of sales: 119.1% of revenue, up 13.4 percentage points from a year ago by our math
- Enrichment unit cost: up 28% from a year ago, against a 10% rise in average selling price
- Selling, general and administrative expenses: 23.8% of revenue, up 11.1 percentage points by our math
- Net loss excluding one-offs: $9.4 million, down from a $5.2 million profit a year ago
Inside the core fuel business, Centrus sells separative work units (SWU), the standard measure of effort needed to enrich uranium. Even though SWU volume rose 19% and average prices rose 10%, the cost per unit jumped 28%, keeping the fuel segment in a $6.9 million gross loss. Meanwhile, overhead and advanced technology costs rose as a share of revenue, pushing the operating loss to $29.7 million.
What to watch: unit cost growth against selling price growth in fourth-quarter deliveries. Another quarter where supply costs outrun billed prices would compress cash flow during the heavy construction phase.
Federal Pullback Hit Technical Solutions and Left Backlog Exposed
The Technical Solutions division runs engineering and fuel production contracts, mostly for the US Department of Energy (DOE). Last quarter, Centrus disclosed that the agency's proposed 2027 budget "does not include further funding for the operation of the HALEU cascade" under the 2022 demonstration contract, and that the customer "does not currently intend to exercise further options under the HALEU Operation Contract".
In the third quarter, that transition hit the income statement. Segment revenue fell 21% from a year ago to $23.7 million because revenue from the HALEU operation contract dropped by $10.2 million, while segment cost of sales still rose 3% to $27.4 million. As a result, Technical Solutions swung from a $3.5 million gross profit a year ago to a $3.7 million gross loss.
Despite the government's stance, the fuel company still carries $0.8 billion for that specific contract, which makes up virtually the entire Technical Solutions backlog. What to watch: Technical Solutions revenue and backlog carrying value at year-end. If commercial HALEU sales do not replace the old government contract dollar for dollar, segment losses will persist and the $0.8 billion backlog will face removal.
Warrant Sale Added $494 Million in Cash and More Shares
Centrus had positioned its $900 million federal expansion award and customer prepayments as ways to fund its plant build-out without issuing heavily dilutive equity. This quarter, the company raised $493.8 million in net proceeds by issuing common stock, pre-funded warrants, and common warrants, and it filed a new shelf registration on November 2.
The financing created a $220.4 million warrant liability on the balance sheet and $4.6 million in one-time issuance expenses inside overhead. Average diluted shares rose 8.4% from a year ago to 22.4 million, and potential dilution will grow if the new warrants are exercised. What to watch: share issuances under the new November shelf registration. Further equity sales while unrestricted cash sits above $2.2 billion would mean the total plant cost is rising well above existing government and customer funding.
Risks this quarter didn't answer
Four standing supply, pricing, and legal risks received no new resolution in the third-quarter earnings release.
- Russian supply reliance and tariffs: the 2026 outlook still relies on "the assumption of no significant change in restrictions in our ability to receive and sell Russian LEU", while trade actions or export bans could disrupt deliveries before 2028.
- The 2028–2029 supply gap: the US ban on Russian uranium takes full effect in January 2028 and new Ohio capacity starts in 2029; the quarterly filing will show if alternative supply was secured.
- Commercial HALEU pricing and prepayments: Centrus began enriching commercial HALEU, but did not disclose unit prices or customer prepayment amounts; December's investor day is the next venue.
- Portsmouth litigation tail: the release gave no update on pending radiation lawsuits; the quarterly filing's legal footnote will show any status change.
👓 Other Themes
Centrus Bought Westerman to Bring Manufacturing In-House
Centrus acquired manufacturing partner Westerman during the period, which Vexler said "helps to derisk our build out and our overall business model" while diversifying operations. The release did not state the purchase price or Westerman's revenue contribution, though net property, plant, and equipment on the balance sheet jumped to $312.9 million from $142.5 million in June.
💲 Other KPIs
Unrestricted cash rose by $278.9 million from the end of 2025, driven by $547.0 million in nine-month financing proceeds from stock and warrant sales. That cash pile earned $16.9 million in quarterly investment income, helping offset operating losses while funding factory construction.
Factory and equipment assets more than doubled from $142.5 million last quarter and rose more than tenfold from $29.5 million at year-end 2025. By our math, Centrus spent $131.6 million on capital expenditures in the third quarter alone, plus another $60.2 million recorded in accounts payable.
Deferred revenue — cash customers have paid upfront for fuel not yet delivered — stood at $86.0 million across current and long-term liabilities, down 34.4% from $131.1 million at the end of 2025 by our math. It stabilized near June's $85.0 million level, showing that new backlog agreements have not yet brought a wave of cash prepayments.
🔮 Guidance
Unchanged. The middle of the range calls for $475 million in sales, or 5.9% growth for the full year by our math. Because nine-month revenue reached $308.3 million, the plan leaves $166.7 million for the fourth quarter at the middle of the range, up 14.0% from last year's fourth quarter due to customer delivery timing. Centrus raised this target by $25 million in the first quarter and held it twice since.
Unchanged. Centrus held its full-year spending plan for the centrifuge build-out for a third straight quarter. Combining $226.4 million of nine-month capital expenditures with $30.0 million of expensed expansion growth costs puts nine-month deployment at $256.4 million by our math. Reaching the $425 million middle of the range requires $168.6 million in the fourth quarter, up from $134.0 million in the third quarter.
Unchanged. The company kept its floor of at least 175 net new workers at the Ohio enrichment plant after raising the target in each of the prior two quarters: +50 in the first quarter and +75 in the second quarter.
Unchanged. Management maintained its target to add at least 100 net new workers at the Tennessee centrifuge factory, a floor held steady all year.
❓ Key Questions
What did Centrus pay for Westerman and what does it earn?
The release announced the Westerman acquisition and showed net property, plant, and equipment jumping by $170.4 million in the quarter, but gave no purchase price, cash outflow split, or revenue contribution from the acquired business.
Why keep $0.8 billion of unfunded government options in backlog?
The Energy Department told Centrus it does not intend to exercise further options on the 2022 HALEU contract and proposed zero funding for 2027, yet the company still reports $0.8 billion of backlog for that contract.
Why raise $494 million via stock and warrants with $2 billion in cash?
Centrus raised $493.8 million from stock and warrants and filed a new shelf registration despite holding over $2.2 billion in cash and a $900 million federal award, raising questions about total project cost.
When do the new definitive backlog contracts pay cash advances?
Binding contingent agreements rose by $2.7 billion to $5.1 billion this quarter, but deferred revenue and customer advances on the balance sheet stayed flat at $86.0 million.
What drove the 28% jump in enrichment unit cost?
The average unit cost of separative work units sold rose 28% from a year ago while average selling prices rose only 10%, keeping the core fuel segment in a gross loss.